WHITE PAPER:
Manufacturers regulated by the FDA 21 CFR Part 11 regulations understand that the integrity of manufacturing processes must be achieved and maintained in order to sustain compliance. The purpose of this document is to demonstrate that Apriso FlexNet platform and application suite can support the intent of the 21 CFR Part 11 regulatory guidelines.
CASE STUDY:
Learn how Kalypsis, a clinical stage pharmaceutical company, is leveraging Xerox DocuShare Enterprise Content Management to control content for regulatory operations and clinical trials.
CASE STUDY:
When GlaxoSmithKline was challenged with improving efficiency in modeling and simulation, their clinical development research team turned to Univa technology for faster methods of establishing and running models for a drug’s effects on the body.
EZINE:
With regulations pushing data protection up the business agenda, we look at how Australia's Notifiable Data Breaches scheme has been received and consider why a survey that found Australian firms are experiencing fewer cyber breach incidents appears to conflict with anecdotal evidence that suggests the opposite.
EGUIDE:
In this e-guide: Computer Weekly has announced the 11th annual UKtech50, our definitive list of the movers and shakers in UK technology – the CIOs, industry executives, public servants and business leaders driving the role of technology in the UK economy.
WHITE PAPER:
Are you sitting on your data with no plan? Do you know how to capitalize on information you already have? This whitepaper dives into the world of profiting from data. Access now to discover 4 essential steps to getting started, as well as challenges to overcome and a discussion on the importance of data integrity.
EZINE:
In this month's CW EMEA, we look at how schools in Germany have stopped using Microsoft Office 365 over lack of clarity over how data is collected, shared and used. We also delve into how former UK spy boss Richard Dearlove leaked names of MI6 secret agent recruiters in China to back an aggressive right-wing US campaign against tech company Huawei.
